Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 19'th Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
09:06am, Tuesday, 19'th Aug 2025
LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
07:00am, Monday, 18'th Aug 2025
Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C. , Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
10:41am, Friday, 15'th Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 31'st Jul 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
07:12am, Wednesday, 30'th Jul 2025
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search Developed in collaboration with Amazon Web Services, Test Finder i
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 29'th Jul 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
07:00am, Tuesday, 29'th Jul 2025
First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU BURLINGTON, N.C. , July 29, 2025 /PRNewswire/ -- La
These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings
09:45am, Friday, 25'th Jul 2025
Labcorp Holdings Inc. LH on Thursday reported stronger-than-expected results for the second quarter.
Labcorp Posts 9.5 Percent Gain in Q2
06:12pm, Thursday, 24'th Jul 2025
Labcorp Posts 9.5 Percent Gain in Q2
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript
02:38pm, Thursday, 24'th Jul 2025
Labcorp Holdings Inc. (NYSE:LH ) Q2 2025 Earnings Conference Call July 24, 2025 9:00 AM ET Company Participants Adam H. Schechter - President, CEO & Chairman Christin O'Donnell - Vice President of Inv
Labcorp (LH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
02:30pm, Thursday, 24'th Jul 2025
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street est
Why Is Testing Giant Labcorp Stock Surging On Thursday?
12:27pm, Thursday, 24'th Jul 2025
Laboratory Corp (NYSE: LH) on Thursday reported second-quarter 2025 adjusted earnings per share of $4.35, up from $3.94 a year ago, beating the consensus of $4.17.
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
11:50am, Thursday, 24'th Jul 2025
LH tops Q2 estimates with double-digit EPS growth, margin gains and a raised 2025 outlook, lifting shares pre-market.
Labcorp Holdings (LH) Q2 Earnings and Revenues Top Estimates
09:01am, Thursday, 24'th Jul 2025
Labcorp Holdings (LH) came out with quarterly earnings of $4.35 per share, beating the Zacks Consensus Estimate of $4.14 per share. This compares to earnings of $3.94 per share a year ago.
